Inogen (INGN) Current Deferred Revenue (2016 - 2022)
Historic Current Deferred Revenue for Inogen (INGN) over the last 10 years, with Q3 2022 value amounting to $9.1 million.
- Inogen's Current Deferred Revenue rose 825.02% to $9.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $9.1 million, marking a year-over-year increase of 825.02%. This contributed to the annual value of $8.6 million for FY2021, which is 2250.5% up from last year.
- Inogen's Current Deferred Revenue amounted to $9.1 million in Q3 2022, which was up 825.02% from $9.0 million recorded in Q2 2022.
- Inogen's 5-year Current Deferred Revenue high stood at $17.1 million for Q4 2019, and its period low was $3.2 million during Q1 2018.
- In the last 5 years, Inogen's Current Deferred Revenue had a median value of $6.6 million in 2020 and averaged $7.0 million.
- Per our database at Business Quant, Inogen's Current Deferred Revenue skyrocketed by 28368.91% in 2019 and then tumbled by 5904.67% in 2020.
- Inogen's Current Deferred Revenue (Quarter) stood at $4.5 million in 2018, then skyrocketed by 283.69% to $17.1 million in 2019, then plummeted by 59.05% to $7.0 million in 2020, then increased by 22.51% to $8.6 million in 2021, then grew by 6.43% to $9.1 million in 2022.
- Its Current Deferred Revenue was $9.1 million in Q3 2022, compared to $9.0 million in Q2 2022 and $8.7 million in Q1 2022.